JP2022543046A5 - - Google Patents
Info
- Publication number
- JP2022543046A5 JP2022543046A5 JP2022506419A JP2022506419A JP2022543046A5 JP 2022543046 A5 JP2022543046 A5 JP 2022543046A5 JP 2022506419 A JP2022506419 A JP 2022506419A JP 2022506419 A JP2022506419 A JP 2022506419A JP 2022543046 A5 JP2022543046 A5 JP 2022543046A5
- Authority
- JP
- Japan
- Prior art keywords
- drawings
- present specification
- invention described
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962880547P | 2019-07-30 | 2019-07-30 | |
| US62/880,547 | 2019-07-30 | ||
| US202062990318P | 2020-03-16 | 2020-03-16 | |
| US62/990,318 | 2020-03-16 | ||
| PCT/US2020/044196 WO2021022008A1 (en) | 2019-07-30 | 2020-07-30 | Virus-like particle vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022543046A JP2022543046A (ja) | 2022-10-07 |
| JP2022543046A5 true JP2022543046A5 (enExample) | 2023-08-07 |
Family
ID=74228282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022506419A Pending JP2022543046A (ja) | 2019-07-30 | 2020-07-30 | ウイルス様粒子ワクチン |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20220280633A1 (enExample) |
| EP (1) | EP4004036A4 (enExample) |
| JP (1) | JP2022543046A (enExample) |
| CN (1) | CN114729030A (enExample) |
| AU (1) | AU2020321021A1 (enExample) |
| CA (1) | CA3149390A1 (enExample) |
| WO (1) | WO2021022008A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3864163T3 (da) | 2018-10-09 | 2024-05-06 | Univ British Columbia | Sammensætninger og systemer omfattende transfektionskompetente vesikler fri for organiske opløsningsmidler og rengøringsmidler og fremgangsmåder forbundet dermed |
| US12630831B2 (en) | 2019-09-29 | 2026-05-19 | Technion Research & Development Foundation Limited | Synthetic non-coding RNAS |
| US20230314432A1 (en) * | 2020-07-10 | 2023-10-05 | Covid Diagnostics Ltd. | Compositions, methods, and systems for detecting immune response |
| CN112760420B (zh) * | 2021-02-05 | 2023-05-26 | 中国科学院长春应用化学研究所 | 一种用于检测新冠病毒SARS-CoV-2的引物、探针和试剂盒 |
| CN114656529B (zh) * | 2021-02-08 | 2024-05-31 | 暨南大学 | 一种新型冠状病毒t细胞的抗原表位肽及其应用 |
| US20220265601A1 (en) * | 2021-02-10 | 2022-08-25 | David Alan Heldreth, JR. | Methods of use and formulations of allosteric modulators of the serotonin, dopamine and other receptor systems for medical, recreational, religious, research and other uses. |
| CN114957409A (zh) * | 2021-02-26 | 2022-08-30 | 中国科学院上海巴斯德研究所 | 基于s蛋白r815位点的冠状病毒干预的方法和产品 |
| WO2022187424A1 (en) * | 2021-03-04 | 2022-09-09 | Helix Nanotechnologies, Inc. | Compositions including sbi adjuvants and methods of use thereof |
| WO2022191742A1 (en) * | 2021-03-11 | 2022-09-15 | Dukhovlinov Ilya Vladimirovich | A method for assessment of the cellular immune |
| AU2022273065A1 (en) * | 2021-05-13 | 2023-11-23 | Benevira Inc. | Methods and compositions for treatment of viral infection |
| WO2022261355A1 (en) * | 2021-06-09 | 2022-12-15 | Chimeron Bio Corporation | Self-amplifying rna-based vlp vaccines |
| CN115572714A (zh) * | 2021-06-21 | 2023-01-06 | 江苏泽凯生物医药技术有限公司 | 一种快速检测SARS-CoV-2病毒中和抗体有效性的方法 |
| US20250082236A1 (en) * | 2021-07-19 | 2025-03-13 | Carnegie Mellon University | Scalable Manufacturing of Microneedle Arrays Using Automated High-Throughput Manufacturing Systems and High-Capacity Molding |
| WO2023023597A1 (en) * | 2021-08-18 | 2023-02-23 | Nanored Llc | Virus-like particle |
| MX2024002259A (es) * | 2021-09-09 | 2024-03-06 | Univ Basel | Acido nucleico producido biologicamente para la produccion de vacunas. |
| WO2023043933A1 (en) * | 2021-09-15 | 2023-03-23 | Verndari, Inc. | Stabilized lipid nanoparticle mrna compositions and uses thereof |
| WO2023062651A1 (en) * | 2021-10-13 | 2023-04-20 | Padmanabh Patil Harshad | Virus-like particles for respiratory syncytial virus and method of preparation thereof |
| RU2769224C1 (ru) * | 2021-12-30 | 2022-03-29 | федеральное государственное бюджетное учреждение «Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи» Министерства здравоохранения Российской Федерации | Рекомбинантные вирусоподобные частицы для индукции специфического иммунитета против вируса тяжелого острого респираторного синдрома SARS-CoV-2 |
| WO2023167868A2 (en) * | 2022-03-01 | 2023-09-07 | Icahn School Of Medicine At Mount Sinai | Immunogenic compositions comprising a recombinant neuraminidase and cpg oligonucleotide adjuvant, and uses thereof |
| KR20260032590A (ko) * | 2023-06-29 | 2026-03-09 | 세퀴러스 인코포레이티드 | 재조합 바이러스 유사 입자 |
| WO2025235418A1 (en) * | 2024-05-05 | 2025-11-13 | National Health Research Institutes | Virus-like particle, preparation method thereof, and use thereof in preparing vaccine |
| WO2025264980A1 (en) * | 2024-06-21 | 2025-12-26 | Georgia Tech Research Corporation | Ambient stabilization of mrna-hybrid lipid nanocapsules in sugar glass |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4148876A (en) * | 1975-09-29 | 1979-04-10 | Burroughs Wellcome Co. | Biological preparations |
| ATE489969T1 (de) * | 2002-06-20 | 2010-12-15 | Cytos Biotechnology Ag | Verpackte virusartige partikel in kombination mit cpg zur verwendung als adjuvantien mit allergenen. herstellungsverfahren und verwendung |
| WO2008103276A2 (en) * | 2007-02-16 | 2008-08-28 | Merck & Co., Inc. | Compositions and methods for potentiated activity of biologicaly active molecules |
| WO2011002522A2 (en) * | 2009-07-02 | 2011-01-06 | Medimmune, Llc | Methods of making and using synthetic viruses |
| US20130259928A1 (en) * | 2010-09-30 | 2013-10-03 | Franvax S.R.L. | Generation of virosome particles |
| PL2811981T3 (pl) * | 2012-02-07 | 2019-09-30 | Infectious Disease Research Institute | Ulepszone formulacje adiuwantowe zawierające agonistę TLR4 oraz sposoby ich zastosowania |
| US10829543B2 (en) * | 2012-10-29 | 2020-11-10 | The University Of North Carolina At Chapel Hill | Compositions and methods for inhibiting pathogen infection |
| CN107073105B (zh) * | 2014-09-12 | 2021-04-06 | 巴斯特威尔控股有限公司 | 用于提供含佐剂病毒体的方法及由此可获得的含佐剂病毒体 |
| WO2016039620A2 (en) * | 2014-09-12 | 2016-03-17 | Bestewil Holding B.V. | Respiratory syncytial virus virosomes |
| WO2017046801A1 (en) * | 2015-09-17 | 2017-03-23 | Ramot At Tel-Aviv University Ltd. | Coronaviruses epitope-based vaccines |
-
2020
- 2020-07-30 US US17/631,435 patent/US20220280633A1/en not_active Abandoned
- 2020-07-30 JP JP2022506419A patent/JP2022543046A/ja active Pending
- 2020-07-30 CA CA3149390A patent/CA3149390A1/en active Pending
- 2020-07-30 WO PCT/US2020/044196 patent/WO2021022008A1/en not_active Ceased
- 2020-07-30 EP EP20847900.6A patent/EP4004036A4/en not_active Withdrawn
- 2020-07-30 AU AU2020321021A patent/AU2020321021A1/en not_active Abandoned
- 2020-07-30 CN CN202080066460.8A patent/CN114729030A/zh active Pending
-
2022
- 2022-01-28 US US17/588,008 patent/US20230000974A1/en active Pending